Mengying Hu
Affiliations: | 2020 | Eshelman School of Pharmacy | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Google:
"Mengying Hu"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang Y, Li S, Hu M, et al. (2024) Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways. Nature Nanotechnology |
| Hu M, Kenific CM, Boudreau N, et al. (2023) Tumor-derived nanoseeds condition the soil for metastatic organotropism. Seminars in Cancer Biology |
| Li Z, Low V, Luga V, et al. (2022) Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nature Communications. 13: 6239 |
| Liu X, Zhou J, Wu H, et al. (2022) Fibrotic immune microenvironment remodelling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Hu M, Huang L. (2022) Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Advanced Drug Delivery Reviews. 183: 114137 |
| Sendi H, Yazdimamaghani M, Hu M, et al. (2021) Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Research |
| Qiu N, Liu Y, Liu Q, et al. (2021) Corrigendum to "Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy" [Biomaterials 269 (2021) 120604]. Biomaterials. 277: 121121 |
| Wang Y, Tiruthani K, Li S, et al. (2021) mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced Materials (Deerfield Beach, Fla.). e2007603 |
| Zhou X, Liu Y, Hu M, et al. (2021) Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Science Advances. 7 |
| Hu M, Wang Y, Liu Z, et al. (2021) Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature Nanotechnology |